Skip to main content

Table 3 Validation of selected targets for microRNAs deregulated in metastatic canine mammary cancer

From: MicroRNA expression patterns in canine mammary cancer show significant differences between metastatic and non-metastatic tumours

Gene

Mean difference

Lower

Upper

p-value

CDC6

1.662166667

0.296219571

3.028113763

0.014739925

CCNE1

1.805333334

0.698148282

2.912518385

0.00111525

MYBL2

1.469333333

0.095498643

2.843168024

0.034267

PDCD10

0.315

−1.466393723

2.096393723

0.899858502

ERBB2IP

1.863333333

0.181873946

3.544792721

0.027609459

SON

1.691333333

0.149694553

3.232972114

0.029382504

STK4

2.356333333

0.708656745

4.004009921

0.004014445

CDC27

2.316333334

0.684213855

3.948452812

0.004297527

PRC1

3.368333333

1.644772232

5.091894434

0.000132898

CDC37

3.250833333

1.273918023

5.227748644

0.001019454

TTK

2.8475

0.856445769

4.838554231

0.004013127

SKIL

2.291666667

0.327926258

4.255407076

0.019726893

BUB3

0.976666667

−0.467839044

2.421172377

0.232448632

SPIN1

1.248333333

−0.448209573

2.944876239

0.180817071

  1. The analysis performed on ten malignant non-metastatic tumours and ten malignant metastatic tumours. Statistical analysis was made on Ct values normalized with a housekeeping gene; one-way ANOVA followed by Tukey’s HSD post hoc tests
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us